Computer-Aided Selective Optimization of Side Activities of Talinolol

Area of Science:

• Drug discovery and medicinal chemistry
• Enzyme inhibition
• Pharmacology

Background:

• Selective optimization of secondary activities can yield novel drug leads.
• Beta-blockers, like talinolol, can have pleiotropic effects beyond their primary therapeutic targets.
• Soluble epoxide hydrolase (sEH) is implicated in various physiological processes.

Purpose of the Study:

• To deorphanize the cholesterol-lowering effects of talinolol using a computer-aided approach.
• To investigate the inhibitory mechanism of talinolol on soluble epoxide hydrolase (sEH).
• To optimize talinolol as a lead structure for drug development.

Main Methods:

• Computer-aided drug design (CADD) for target deconvolution.
• X-ray crystallography to determine the structure of sEH bound to talinolol.
• In vivo efficacy testing in an animal model.

Main Results:

• Talinolol's cholesterol-lowering effects were attributed to the inhibition of soluble epoxide hydrolase (sEH).
• X-ray structure analysis provided insights for optimizing talinolol's inhibitory potency against sEH.
• The optimized lead structure demonstrated in vivo activity in a rat model of diabetic neuropathic pain.

Conclusions:

• Talinolol's pleiotropic effects can be explained by sEH inhibition.
• Structure-based drug design enabled the optimization of talinolol's inhibitory activity.
• The findings support the development of sEH inhibitors for conditions like diabetic neuropathic pain.